Sort   by:  
 Page size 
UnknownTris[bis-(2-methyl-prop-yl)dithio-phosphinato]bis-muth(III).
Not available
S-EPMC2979605 | biostudies-literature
UnknownComposite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase II Trial.
Not available
S-EPMC7702129 | biostudies-literature
UnknownEffects of ustekinumab on spondylitis-associated endpoints in TNFi-naive active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials.
Not available
S-EPMC7046941 | biostudies-literature
UnknownA head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naive patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial.
Not available
S-EPMC6937408 | biostudies-literature
UnknownGuselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis.
Not available
S-EPMC9891416 | biostudies-literature
UnknownMeaningful Improvement in General Health Outcomes with Guselkumab Treatment for Psoriatic Arthritis: Patient-Reported Outcomes Measurement Information System-29 Results from a Phase 3 Study.
Not available
S-EPMC9584870 | biostudies-literature
UnknownImpact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study.
Not available
S-EPMC7425189 | biostudies-literature
UnknownEfficacy and safety of guselkumab in biologic-naive patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial.
Not available
S-EPMC9444112 | biostudies-literature
UnknownGuselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naive or TNFα inhibitor-experienced.
Not available
S-EPMC7880108 | biostudies-literature
UnknownComparative Genetic Analysis of Psoriatic Arthritis and Psoriasis for the Discovery of Genetic Risk Factors and Risk Prediction Modeling.
Not available
S-EPMC9539852 | biostudies-literature
Sort   by:  
 Page size